Skip to main content
padlock icon - secure page this page is secure

Immunologic Modulations to Enhance Post-Stroke Recovery

Buy Article:

$68.00 + tax (Refund Policy)

Stroke is one of the leading causes of death and disability worldwide. The limited utility of current treatments, the increasing rates of stroke survivorship and subsequent long-term disability necessitate novel approaches to improve functional recovery after injury. The underlying immune mechanisms mediating inflammation and subsequent repair beyond the acute phase of injury remain understudied. The relative balance of injury and repair is dependent in part on the polarization state of microglia, the resident tissue macrophage of the central nervous system. Microglia can be classically activated to a pro-inflammatory phenotype, or alternatively activated to an immunomodulatory, tissue repair phenotype depending on the balance of local environmental cues. Once activated, they orchestrate a complex symphony of inflammation and repair, interacting with both the peripheral immune system and local cells such as astrocytes and neural stem cells to coordinate the resolution of inflammation and repair of damaged tissues. Furthermore, neural stem cells and astrocytes themselves appear to have intrinsic immunomodulatory properties which could be used in the development of future therapies. Enhancing these “reparative” functions with pharmacologic agents could open up exciting new avenues to improve long-term functional recovery in stroke patients.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Inflammation; ischemia; microglia; recovery; stem cell; stroke; tissue repair

Document Type: Research Article

Publication date: August 1, 2015

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more